Abstract
A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Risk of Hematological Toxicities in Patients with Multiple Myeloma Treated with Daratumumab
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have